Full disclosure - Out-of-pocket costs as side effects

New England Journal of Medicine

Volumn 369, Issue 16, 2013, Pages 1484-1486

  Ubel, Peter A ^a,b   Abernethy, Amy P ^b,c,d   Zafar, S Yousuf ^b,c,d  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CANCER CHEMOTHERAPY; CLINICAL DECISION MAKING; COST CONTROL; COST OF ILLNESS; DOCTOR PATIENT RELATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MEDICAL PRACTICE; PATIENT DECISION MAKING; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY;

EID: 84885822183     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1306826     Document Type: Article

References (5)

1. Centers for Medicare & Medicaid Services. 2013 ASP drug pricing files. 2013 (http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/ McrPartBDrugAvgSalesPrice/2013ASPFiles.html).
2. Center for American Progress Action Fund. Coverage when it counts: how much protection does health insurance offer and how can consumers know? May 2009 (http://www.americanprogressaction.org/wp-content/uploads/issues/2009/05/pdf/ CoverageWhenItCounts.pdf).
3. National Center for Health Statistics. Financial burden of medical care: early release of estimates from the National Health Interview Survey, January-June 2011. 2012 (http://www.cdc.gov/nchs/data/nhis/earlyrelease/ financial-burden-of-medical-care-032012.pdf).
4. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 2013;18:381-90.
5. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003;290:953-8.